XML 63 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated other comprehensive loss
Retained Earnings (Accumulated Deficit)
Balance, shares at Dec. 31, 2020   8,876,515      
Balance, amount at Dec. 31, 2020 $ 40,551,723 $ 8,876 $ 100,504,741 $ (104,615) $ (59,857,279)
Issuance of common stock - options exercises, shares   2,500      
Issuance of common stock - options exercises, amount 10,250 $ 2 10,248 0 0
Issuance of common stock - restricted, shares   91,650      
Issuance of common stock - restricted, amount (140,894) $ 92 (140,986) 0 0
Issuance of common stock through at-the-market offering program, net of issuance costs of $333,305, shares   100,687      
Issuance of common stock through at-the-market offering program, net of issuance costs of $333,305, amount 1,088,398 $ 101 1,088,297 0 0
Stock compensation expense -   0      
restricted 157,107   157,107 0 0
Stock compensation expense - non-qualified stock options 25,735 0 25,735 0 0
Foreign currency translation - loss (54,949) 0   (54,949) 0
Net income (loss) 585,424 0 0 0 585,424
Balance, amount at Mar. 31, 2021 42,222,794 $ 9,071 101,645,142 (159,564) (59,271,855)
Balance shares June 30,2022 at Mar. 31, 2021   9,071,352      
Balance, shares at Dec. 31, 2020   8,876,515      
Balance, amount at Dec. 31, 2020 40,551,723 $ 8,876 100,504,741 (104,615) (59,857,279)
Net income (loss) 380,693        
Balance, amount at Jun. 30, 2021 42,264,193 $ 9,100 101,871,610 (139,931) (59,476,586)
Balance shares June 30,2022 at Jun. 30, 2021   9,099,560      
Balance, shares at Mar. 31, 2021   9,071,352      
Balance, amount at Mar. 31, 2021 42,222,794 $ 9,071 101,645,142 (159,564) (59,271,855)
Issuance of common stock through at-the-market offering program, net of issuance costs of $333,305, amount (17,324) 0 (17,324) 0 0
restricted 214,852 0 214,852 0 0
Stock compensation expense - non-qualified stock options 28,969 0 28,969 0 0
Foreign currency translation - loss 19,633 $ 0 0 19,633 0
restricted, shares   28,208      
restricted, amount 0 $ 29 (29) 0 0
Net income (loss) (204,731) 0 0 0 (204,731)
Balance, amount at Jun. 30, 2021 42,264,193 $ 9,100 101,871,610 (139,931) (59,476,586)
Balance shares June 30,2022 at Jun. 30, 2021   9,099,560      
Balance, shares at Dec. 31, 2021   8,842,026      
Balance, amount at Dec. 31, 2021 41,675,995 $ 8,842 101,424,922 (241,586) (59,516,183)
Issuance of common stock - restricted, shares   50,345      
restricted 179,741 $ 0 179,741 0 0
Foreign currency translation - loss (4,835) 0 0 (4,835) 0
Net income (loss) (392,897) $ 0 0   (392,897)
Common Stock repurchased,Shares   196,586      
Common stock repurchased amount (818,211) $ (197) (818,014)    
Issuance of common stock - restricted amount (49,224) 51 (49,275) 0 0
Issuance of common stock - warrants 108,000 0 108,000 0 0
Balance, amount at Mar. 31, 2022 40,698,569 $ 8,696 100,845,374 (246,421) (59,909,080)
Balance shares June 30,2022 at Mar. 31, 2022   8,695,785      
Balance, shares at Dec. 31, 2021   8,842,026      
Balance, amount at Dec. 31, 2021 41,675,995 $ 8,842 101,424,922 (241,586) (59,516,183)
Net income (loss) (14,152,106)        
Balance, amount at Jun. 30, 2022 26,893,891 $ 8,726 100,934,729 (381,275) (73,668,289)
Balance shares June 30,2022 at Jun. 30, 2022   8,725,476      
Balance, shares at Mar. 31, 2022   8,695,785      
Balance, amount at Mar. 31, 2022 40,698,569 $ 8,696 100,845,374 (246,421) (59,909,080)
Issuance of common stock - restricted, shares   29,691      
Issuance of common stock - restricted, amount 0 $ 30 (30) 0 0
restricted 89,385 0 89,385 0 0
Foreign currency translation - loss (134,854) 0 0 (134,854) 0
Net income (loss) (13,759,209) 0 0 0 (13,759,209)
Balance, amount at Jun. 30, 2022 $ 26,893,891 $ 8,726 $ 100,934,729 $ (381,275) $ (73,668,289)
Balance shares June 30,2022 at Jun. 30, 2022   8,725,476